[1]
|
Jadvar H,Connolly LP,Fahey FH,et al.PET and PET/CT in pediatric oncology.Semin Nucl Med,2007,37(5):316-331. |
[2]
|
Gelfand MJ,Lemen LC.PET/CT and SPECT/CT dosimetry in children:The challenge to the pediatric imager.Semin Nucl Med,2007,37(5):391-398. |
[3]
|
Hahn K.Pfluger T.Is PET/CT necessary in paediatric oncolngy? Against.Eur J Nucl Med Mol Imaging,2006,33(8):966-968. |
[4]
|
Munson S,Eshel N,Ernst M,et al.Ethics of PET research in children//charron M.Pediatric PET imaging.New York:Springer New York,2006:72-91. |
[5]
|
Nanni C,Rubello D,CasteUueci P,et al.18F-FDG PET/CT fusion imaging in pediatric solid extracranial turnouts.Biomed Pharnmacother,2006,60(9):593-606. |
[6]
|
Wegner EA,Barrington SF,Kingston JE,et al.The impact of PET scanning on management of pediatric oncology patients.Eur J Nucl Med Mol Imaging,2005,32(1):23-30. |
[7]
|
Kabickova E,Sumeraner D,Cumlivska E,et al.Comparison of 18F-FDG-PET and standard procedures for the pretreatment staging of children and adolescents with Hodgkin's disease.Eur Nucl Med Mol Imaging,2006,33(9):1025-1031. |
[8]
|
Miller E,Metser U,Avrahami G,et al.Role of 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients.J Comput Assist Tomogr,2006,30(4):689-694. |
[9]
|
Certh HU,Juergens KU,Dirkson U,et al.Significant benefit of multimodal imaging:PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.J Nucl Med,2007,48(12):1932-1939. |
[10]
|
Liuabery AM,Ross JA.Trends in childhood cancer incidence in the U.S.(1992-2004).Cancer,2008,112(2):416-432. |
[11]
|
Tatsumi M,Miller JH,Wahl RL.18F-FDG PET/CT in evaluating non-CNS pediatric malignancies.J Nucl Med,2007,48(12):1923-1931. |
[12]
|
Rhodes MM,Delbeke D,Whitlock JA,et al.Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma-J Pediatr Hematol Oncol,2006,28(5):300-306. |
[13]
|
Patil S,Biassoni L,Borgwardt L Nuclear medicine in pediatric neurology and neurosurgery:epilepsy and brain tumors.Semin Nucl Med,2007,37(5):357-381. |
[14]
|
Ishola TA,Chung DH.Neuroblastoma.Surg Oncol,2007,16(3):149-156. |
[15]
|
Maris JM,Hogarty MD,Bagatell R.et al.Neuroblastoma.Lancet,2007,369(9579):2106-2120. |
[16]
|
Federman N,Feig SA.PET/CT in evaluating pediatric malignancies:a clinician's perspective.J Nucl Med,2007,48(12):1920-1922. |
[17]
|
Chawla M,NC,Agarwala S,et al.Serial renal dynamic scintigraphy in evaluation of renal function in patient with bilateral Wilms' tumors.Clin Nucl Med,2005,30(12):820-822. |
[18]
|
McLean TW,Castellino SM.Pediatric genitourinary tumors.Curr Opin Oncol,2008,20(3):315-320. |
[19]
|
Misch D,Steffen IG,Schonberger S,et al.Use of positron emission temography for staging,preoperative response assessment and posttherapeutic evaluation in children with Wilms tumour.Eur J Nucl Med Mol Imaging,2008,35(9):1642-1650. |
[20]
|
Leaphart C,Rodeberg D.Pediatric surgical ontology:management of rhabdomyosarcoma.Surg Oncol,2007,16(3):173-185. |
[21]
|
Klem ML,Grewal RK,Wexler LH,et al.PET for staging in rhabdornyosarcoma:an evaluation of PET as an adjunct to current staging tools.J Pediatr Hematol Oncol,2007,29(1):9-14. |
[22]
|
Peng F,Rabkin G,Muzik O.Use of 2-doxy-2-[F-18]-fluoro-Dglucose positron emission tomography to monitor therapeutic response by rhabdomyosareoma in children:report of a retrospective case study.Clin Nucl Med,2006,31(7):394-397. |